| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05940493 | Abemaciclib in Newly Diagnosed Meningioma Patients | Meningioma | Recruiting |
| Early Phase 1 | |||
| NCT07268053 | A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted… | Glioblastoma (GBM) | Recruiting |
| NCT07485049 | BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors | Glioblastoma (GBM) | Recruiting |
| NCT06883747 | Clinical Trial of BMS-986504 in Recurrent GBM Patients | Glioblastoma WHO Grade IV | Recruiting |
| NCT02933736 | Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients | Glioblastoma Multiforme | Active, Not Recruiting |
| NCT05076513 | Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma | Glioblastoma | Active, Not Recruiting |
| NCT05182905 | AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients | Glioblastoma | Active, Not Recruiting |
| NCT06824662 | Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in… | Glioblastoma WHO Grade IV | Active, Not Recruiting |